OTC Healthcare - Colombia
OTC Healthcare in Colombia : Market Insight
EXECUTIVE SUMMARY
Positive growth continues in 2006 Direct sellers boost vitamins and dietary supplements Competition intensifies in many areas Distribution concentrated in grocery outlets and chemists/pharmacies Saturation ahead for forecast period KEY TRENDS AND DEVELOPMENTS
Improvements in economy encourage growth Health and wellness has increasing influence on OTC healthcare High pollution benefits cough, cold and allergy (hay fever) remedies Self-medication continues to grow Grocery outlets lead distribution of OTC healthcare Direct sellers continue to strengthen positioning Ineffective price and distribution regulations APPENDIX
OTC registration and classification De-listing or de-reimbursement Advertising Packaging and Labelling Distribution Vitamins and dietary supplements registration and classification Generics Switches Consumer expenditure on health goods and medical services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2006
MARKET INDICATORS
Table 2 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 7 Penetration of Private Label by Sector 2002-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - Colombia
Farma de Colombia SA, Grupo - OTC Healthcare - Colombia
STRATEGIC DIRECTION KEY FACTS
Summary 2 Farma de Colombia SA, Grupo: Key Facts
Summary 3 Grupo Farma: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Farma de Colombia SA, Grupo: Competitive Position 2006
Lafrancol SA - OTC Healthcare - Colombia
STRATEGIC DIRECTION KEY FACTS
Summary 5 Lafrancol SA: Key Facts
Summary 6 Lafrancol SA: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 7 Lafrancol SA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Lafrancol SA: Competitive Position 2006
Omnilife Manufactura de Colombia Ltda - OTC Healthcare - Colombia
STRATEGIC DIRECTION KEY FACTS
Summary 9 Omnilife Manufactura de Colombia Ltda: Key Facts
Summary 10 Omnilife Manufactura de Colombia Ltda: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 11 Omnilife Manufactura de Colombia Ltda: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 12 Omnilife: Competitive Position 2006
Procaps SA, Laboratorios - OTC Healthcare - Colombia
STRATEGIC DIRECTION KEY FACTS
Summary 13 Procaps SA, Laboratorios: Key Facts
Summary 14 Procaps: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 15 Procaps SA, Laboratorios: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 16 Procaps SA, Laboratorios: Competitive Position 2006
Tecnoqumicas SA - OTC Healthcare - Colombia
STRATEGIC DIRECTION KEY FACTS
Summary 17 Tecnoqumicas SA: Key Facts
Summary 18 Tecnoqumicas SA: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 19 Tecnoqumicas SA: Production Statistics 2004
COMPETITIVE POSITIONING
Summary 20 Tecnoqumicas SA: Competitive Position 2006
NRT Smoking cessation aids in Colombia
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 12 Number of Smokers by Gender 2001-2006
Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 15 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 16 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011